Comparative analysis of immune checkpoint inhibitors and chemotherapy in the treatment of advanced non-small cell lung cancer: A meta-analysis of randomized controlled trials

BACKGROUND: Recently, immune checkpoint inhibitors have shown survival advantage over chemotherapy in the treatment of advanced non-small cell lung cancer (NSCLC). This meta-analysis was conducted to gather and analyze the available evidence (Evidence level I; Randomized Controlled Trials) comparing...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Muhammad, Lin, Jie, Liao, Guixiang, Tian, Yunhong, Liang, Yingying, Li, Rong, Liu, Mengzhong, Yuan, Yawei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6113026/
https://www.ncbi.nlm.nih.gov/pubmed/30113497
http://dx.doi.org/10.1097/MD.0000000000011936

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6113026/
https://www.ncbi.nlm.nih.gov/pubmed/30113497
http://dx.doi.org/10.1097/MD.0000000000011936

Ejemplares similares